|
【结 构 式】 
|
【药物名称】AIT-034 【化学名称】3-(6-Oxo-1,6-dihydro-9H-purin-9-yl)-N-[3-(2-oxopyrrolidin-1-yl)propyl]propanamide 【CA登记号】138117-48-3 【 分 子 式 】C15H20N6O3 【 分 子 量 】332.36505 |
【开发单位】Spectrum Pharmaceuticals (Originator) 【药理作用】Cognition Disorders, Treatment of, NEUROLOGIC DRUGS |
合成路线1
The condensation of adenine (I) with ethyl acrylate (II) by means of NaOEt in refluxing ethanol gives 3-(6-amino-1,6-dihydro-9H-purin-9-yl)propionic acid ethyl ester (III), which is treated with NaNO2 and HOAc to yield 3-(6-oxo-1,6-dihydro-9H-purin-9-yl)propionic acid ethyl ester (IV). Finally, this compound is treated with 1-(3-aminopropyl)-2-pyrrolidinone (V) in refluxing acetonitrile to afford the target propionamide.
| 【1】 Glasky, A.J.; Multi-functional pharmaceutical cpds. and methods of use. WO 9114434 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 10343 | 9H-Purin-6-amine; 9H-Purin-6-ylamine; Adenine | 73-24-5 | C5H5N5 | 详情 | 详情 |
| (II) | 10164 | ethyl acrylate | 140-88-5 | C5H8O2 | 详情 | 详情 |
| (III) | 54214 | ethyl 3-(6-amino-1,6-dihydro-9H-purin-9-yl)propanoate | n/a | C10H15N5O2 | 详情 | 详情 |
| (IV) | 16494 | ethyl 3-(6-oxo-1,6-dihydro-9H-purin-9-yl)propanoate | C10H12N4O3 | 详情 | 详情 | |
| (V) | 52036 | N-(3-Aminopropyl)-2-pyrrolidinone; N-(3'-Aminopropyl)-2-pyrrolidinone | 7663-77-6 | C7H14N2O | 详情 | 详情 |
Extended Information